June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Hyperhomocysteinemia and Epigenetic Modifications in Diabetic Retinopathy
Author Affiliations & Notes
  • Ghulam Mohammad
    Ophthalmology, WAYNE STATE UNIVERSITY, Detroit, Michigan, United States
  • Renu Kowluru
    Ophthalmology, WAYNE STATE UNIVERSITY, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Ghulam Mohammad, None; Renu Kowluru, None
  • Footnotes
    Support  RO1 EY014370; RO1 EY017313; RO1 EY022230
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1783. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ghulam Mohammad, Renu Kowluru; Hyperhomocysteinemia and Epigenetic Modifications in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1783.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Activation of retinal matrix metalloproteinase-9 (MMP-9) in diabetes is associated with accelerated capillary cell apoptosis. We have shown that the MMP-9 promoter undergoes epigenetic modifications, and its DNA is hydroxymethylated. Diabetic patients also have increased circulating homocysteine levels, and hyperhomocysteinemia is now considered as a risk factor for the development of diabetic retinopathy. Our aim was to investigate the role of homocysteine in the development of diabetic retinopathy.

Methods : Human retinal endothelial cells (HRECs) incubated in high glucose, in the presence or absence of 100μM homocysteine, were analyzed for the expression of MMP-9 and its tissue inhibitor Timp1, DNA methylation machinery, and cell apoptosis. DNA methylation status of MMP-9 and Timp1 promoters was determined by quantifying methylated cytosine (5mC) and 5-hydroxy methylcytosine (5hmC) using immuno-capture technique. The binding of DNA methyl transferase-1 (Dnmt1) and hydroxymethylation enzymes Ten-Eleven Translocase-2 (Tet2) at the promoters were investigated by chromatin immunoprecipitation technique. Similar studies were performed in the retinal microvessels (using hypotonic method) from streptozotocin-induced diabetic rats received intraperitoneal administration of homocysteine (100μg/ kg BW/day) for 8 weeks.

Results : Supplementation of homocysteine in a high glucose medium synergistically increased MMP-9, decreased Timp1, and exacerbated endothelial cell apoptosis. Compared to high glucose alone, Dnmt and Tet were also further increased, and while MMP-9 promoter had increased 5hmC, Dnmt1 and Te2 binding, Timp1 promoter had increased 5mC. Similar changes in dynamic DNA methylation were observed at the promoters of MMP-9 and Timp1 in the retinal microvessels from diabetic rats that received homocysteine.

Conclusions : Increased homocysteine in diabetic environment epigenetically modifies both MMP-9 and its tissue inhibitor, exacerbating MMP-9 activation and capillary cell apoptosis. Thus, managing hyperhomocysteinemia in diabetic patients could protect retinal capillary cells from undergoing accelerated apoptosis, and slow down the development of retinopathy.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×